Advertisement

PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 38–38 | Cite as

NICE recommends ocrelizumab for primary progressive MS

News item
  • 6 Downloads

Reference

  1. NICE. Ocrelizumab for treating primary progressive multiple sclerosis Internet Document : 9 May 2019. Available from: URL: https://www.nice.org.uk/guidance/gid-ta10153/documents/final-appraisal-determination-document-2

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations